glycerol has been researched along with Influenza, Human in 9 studies
Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.
Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prior influenza vaccination had no effect on study outcome." | 2.84 | Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections. ( Adkins, I; Arters, K; Buchheit, K; Esper, F; Ghannoum, MA; Mukherjee, PK; Salata, RA, 2017) |
| "With the current knowledge of influenza A virus (IAV), we designed a nanoparticle-based inhibitor (nano-inhibitor) that has a matched nanotopology to IAV virions and shows heteromultivalent inhibitory effects on hemagglutinin and neuraminidase." | 1.56 | Topology-Matching Design of an Influenza-Neutralizing Spiky Nanoparticle-Based Inhibitor with a Dual Mode of Action. ( Bhatia, S; Cheng, C; Haag, R; Kerkhoff, Y; Nie, C; Oehrl, A; Parshad, B; Stadtmüller, M; Wolff, T, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nie, C | 1 |
| Parshad, B | 1 |
| Bhatia, S | 2 |
| Cheng, C | 1 |
| Stadtmüller, M | 2 |
| Oehrl, A | 1 |
| Kerkhoff, Y | 1 |
| Wolff, T | 2 |
| Haag, R | 2 |
| Zhong, M | 1 |
| Yu, Y | 1 |
| Song, JQ | 1 |
| Jia, TW | 1 |
| Liu, AY | 1 |
| Zhao, TF | 1 |
| He, HJ | 1 |
| Yang, MB | 1 |
| Zhang, WX | 1 |
| Yang, Y | 1 |
| Correia, R | 1 |
| Meneses, L | 1 |
| Richheimer, C | 1 |
| Alves, PM | 1 |
| Carrondo, MJT | 1 |
| Duarte, ARC | 1 |
| Paiva, A | 1 |
| Roldão, A | 1 |
| Lauster, D | 1 |
| Bardua, M | 1 |
| Ludwig, K | 1 |
| Angioletti-Uberti, S | 1 |
| Popp, N | 1 |
| Hoffmann, U | 1 |
| Paulus, F | 1 |
| Budt, M | 1 |
| Hamann, A | 1 |
| Böttcher, C | 1 |
| Herrmann, A | 1 |
| Mukherjee, PK | 1 |
| Esper, F | 1 |
| Buchheit, K | 1 |
| Arters, K | 1 |
| Adkins, I | 1 |
| Ghannoum, MA | 1 |
| Salata, RA | 1 |
| BRAND, G | 1 |
| KEIL, AW | 1 |
| Purevsuren, J | 1 |
| Hasegawa, Y | 1 |
| Kobayashi, H | 1 |
| Endo, M | 1 |
| Yamaguchi, S | 1 |
| Buchen, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo to Prevent Acute Upper Respiratory Disease and Respiratory Virus Infections[NCT02644135] | 100 participants (Actual) | Interventional | 2013-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Measured by medical record review. (NCT02644135)
Timeframe: Through study duration, an average of 3 months
| Intervention | Number of acute respiratory illnesses (Number) |
|---|---|
| Halo Oral Spray | 4 |
| Halo Placebo | 2 |
(NCT02644135)
Timeframe: Through study duration, an average of 3 months
| Intervention | participants (Number) |
|---|---|
| Halo Oral Spray | 2 |
| Halo Placebo | 4 |
1 trial available for glycerol and Influenza, Human
| Article | Year |
|---|---|
Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Infective Agents, Local; Cety | 2017 |
8 other studies available for glycerol and Influenza, Human
| Article | Year |
|---|---|
Topology-Matching Design of an Influenza-Neutralizing Spiky Nanoparticle-Based Inhibitor with a Dual Mode of Action.
Topics: Animals; Antiviral Agents; Dogs; Drug Design; Glycerol; Humans; Influenza A virus; Influenza, Human; | 2020 |
Amide-sialoside protein conjugates as neomucin bioshields prevent influenza virus infection.
Topics: Amides; Animals; Antiviral Agents; Cattle; Drug Combinations; Glycerol; Hemagglutinin Glycoproteins, | 2020 |
Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system.
Topics: Antibodies, Viral; Glycerol; Hemagglutinin Glycoproteins, Influenza Virus; Hemagglutinins; Humans; I | 2021 |
Linear polysialoside outperforms dendritic analogs for inhibition of influenza virus infection in vitro and in vivo.
Topics: Analysis of Variance; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Dogs; Drug Syner | 2017 |
Best drugs for what ails you: the brands to buy--and those to skip.
Topics: Acetaminophen; Anesthetics, Local; Cetirizine; Chlorpheniramine; Common Cold; Cough; Dextromethorpha | 2009 |
[Concentration of complement-binding influenza antigen by glycerin dialysis].
Topics: Adaptive Immunity; Antigens; Complement System Proteins; Dialysis; Glycerol; Humans; Immune System P | 1955 |
Urinary organic metabolite screening of children with influenza-associated encephalopathy for inborn errors of metabolism using GC/MS.
Topics: Amino Acid Metabolism, Inborn Errors; Child; Child, Preschool; Encephalitis, Viral; Female; Gas Chro | 2008 |
News 2009.
Topics: Climate Change; Economic Recession; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Moon; | 2009 |